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HMG-CoA reductase inhibitors induce apoptosis in mouse proximal
tubular cells in primary culture. Renal cyst formation in polycystic
diseases or after nephron reduction is attributed to enhanced tubular cell
proliferation with unbalanced cell death. The induction of tubular cell
death could be effective to reduce renal cyst formation. In this study, we
examined the effects of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-
C0A) reductase inhibitors on apoptosis in mouse proximal tubular (MPT)
cells in primary culture. After treatment with HMG-CoA reductase
inhibitors, the extracted DNA was analyzed by gel-electrophoresis under
ultraviolet light. Apoptosis was evaluated quantitatively by estimating the
ratio of fragmented DNA over intact DNA. For morphologic studies, cells
were stained with Hoechst 33258. DNA ladder pattern of 200 kDa typical
of apoptosis and significant increase in DNA fragmentation were seen
after 24 hours of treatment with lovastatin, a HMG-CoA reductase
inhibitor. Staining with the Hoechst dye revealed cleavage of nucleus into
pieces under the same condition. Geranylgeranylpyrophosphate (20 tLM)
and mevalonate (500 jiM) completely reversed the effect of lovastatin,
while farnesylpyrophosphate (20 jiM) partially reversed it. Other products
of HMG-CoA pathway such as cholesterol, ubiquinone, dolichol, and
isopcntenyladenine had no effect. Perillic acid and a-hydoxyfarnesylphos-
phonic acid, isoprenylation inhibitors, induced apoptosis of the cells. A
treatment with lovastatin caused actin filament disruption. Cytochalasin
D, an inhibitor of aeOn polymerization, induced apoptosis. Interleukin-
1/3-converting enzyme inhibitor II, a protease inhibitor, had no effect on
the apoptosis induced by either HRI or cytochalasin D. The present study
suggests that in mouse proximal tubules, HMG-CoA reductase inhibitors
induce apoptosis via inhibition of isoprenoid production, and disruption of
actin filaments may play a role in the apoptosis induction.
Renal cyst formation is observed not only in hereditary diseases
like autosomal dominant or recessive polycystic kidney diseases,
but also in patients with chronic renal failure [1—3]. Although the
mechanisms of cyst formation in these diseases are not clearly
understood, sustained cell proliferation in the cyst lining epithe-
hum is thought to be one of the important factors [4—7]. Under
the hypothesis that suppression of tubular cell proliferation could
be effective in reducing cyst formation, antiproliferative agents
have been tried for the treatment of cyst formative diseases using
in vitro and in vivo models. Taxol, a modulator of microtubules
and also known to have an anti-tumor effect, suppressed collect-
ing-duct cyst enlargement in a cpk mouse, a model of autosomal
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recessive polycystic kidney disease [8]. Recently lovastatin, a
3-hydroxy-3-methylglutaryl coenzyme A (HMG-C0A) reductase
inhibitor, was reported to decrease cyst formation with the
amelioration of renal injury in Han:SPRD rats, a model of
autosomal dominant polycystic kidney disease [91. However, the
pathway by which HMG-CoA reductase inhibitors (HRI) sup-
presses cell proliferation of cyst lining epithelium has not been
addressed in the study.
As shown in Figure 1, HRI inhibit HMG-CoA reductase, which
catalyzes HMG-CoA to produce mevalonate metabolites such as
ubiquinone, dolichol, isopentenyladenine, cholesterol, farnesylpy-
rophosphate (FPP) and geranylgeranylpyrophosphate (GGPP)
[10—12]. To maintain a constant production of these mevalonate
products, cells have to regulate this pathway precisely. Inhibition
of HMG-CoA reductase has been shown not only to inhibit cell
proliferation in mesangial cells [13] but also to induce apoptosis in
an ovarian cell line [14], in murine B cells [15], in glioma cells [161
and in HL-60 cells [17]. With regards to the mechanism, the role
of FPP has been the focus of study because Ras proteins are
known to need FPP for the activation [14, 18—201. To date,
however, the mechanism of the antiproliferative effect still re-
mains unclear. GGPP, another isoprenoid whose production is
suppressed by HRI, is essential for the activation of both Rho and
Rab proteins [21]. The exact role of these two proteins in cell
functions is not yet clearly defined, but recently it has become
apparent that members of the Rho proteins play key roles in the
dynamic organization of the actin cytoskeleton [22—24]. In turn,
lovastatin was reported to induce disruption of actin stress fibers
in a renal carcinoma cell line [25] and NIH3T3 cells [26].
Interestingly, GGTI-298, an inhibitor of geranylgeranylation, dis-
rupted stress fiber formation, while FTI-277, an inhibitor of
farnesylation, had no effect [26].
Recent studies have shown that extracellular matrix compo-
nents and cytoskeleton play some roles in cell apoptosis. Vitro-
nectin and fibronectin were demonstrated to be potent in sup-
pressing apoptosis in mesangial cells [27]. In irradiated HL-60
cells, depolymerization of F-actin was observed to occur before
the apoptotic body formation [281. In rat cultured renal proximal
cells, treatment with a nephrotoxin induced F-actin disruption
that appeared to precede nucleus fragmentation [29]. Actin
filament disorganization, itself caused by cytochalasin D, induced
apoptosis in the study. The exact role of these extracellular matrix
and cytoskeleton components in apoptosis has not yet been
elucidated, however, it is tempting to think that HRI would induce
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In the present study, we have examined whether HRI induce
apoptosis of mouse proximal tubular (MPT) cells in primary
culture. The results demonstrate that HRI induce apoptosis of
MPT cells, and that the suppression of GGPP production rather
than FPP is critical in that apoptosis induction. Furthermore, we
have investigated the effect of HRI on actin filaments, and found
that HRI disrupt actin filament bundles of MPT cells before the
nuclear cleavage. These data support the hypothesis that HRI
induce apoptosis through actin disorganization.
These in vitro findings suggest further evaluation of HRI as
potential therapeutic agents for the treatment of cyst formation of




Culturc media and reagents were from Gibco-BRL (Eragny,
France). Percoll was purchased from Pharmacia AB (Uppsala,
Sweden). Animal were Iffa Credo (France). Perillic acid, a-
hydoxyfarnesylphosphonic acid (HFPA) and interleukin-1-con-
verting enzyme inhibitor II (ICE-TI) were from Calbiochem (La
Jolla, CA, USA). Rhodamine phalloidin was from Molecular
Probes (Eugene, OR, USA). [3H]-thymidine was from Amersham
(Amcrsham, UK). Lovastatin and simvastatin were kindly pro-
vided by Merk Sharp & Dohme-Chibret. All other chemicals were
from Sigma (St. Louis, MO, USA).
The molecules of lovastatin, simvastatin, and compactin were
converted to their active forms as described by Kita, Borwn and
Goldstein [30]. To produce the mevalonate salt, 13 mg of meva-
Fig. 1. The mevalonate pathway.
Ionic acid lactone were incubated in 0.1 N NaOH (2 hr, 50°C, pH
7.4); the 0.1 M stock solution was stored at —20°C.
Cell culture
Mouse proximal tubule cells were isolated as described by
Vinay, Gougoux and Lemieux [31] and grown as described for
other species with some modifications [32, 33]. Briefly, kidneys
were removed aseptically from anesthetized C57BL6 mice (0.1 to
0.15 kg), decapsulated and sliced in 1 mm-thick sections which
were kept 4°C in Hank's balanced salt solution supplemented with
10 m N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid
(Hepes) and 5mM D-glucose, pH = 7.4 (HBS-Hepes). Cortex was
separated from medulla, cortical slices were rinsed three times in
HBS-Hepes, and placed in a mixture of 5 ml HBS-Hepes, 5 ml of
culture medium, 25 mg bovine serum albumin and 10 mg colla-
genase. This suspension was transferred to a trypsinizing flask,
and was incubated under gentle stirring during 30 minutes at 37°C
in a 5% CO2 to 95% air atmosphere. Homogeneous populations
of nephron segments were separated by Percoll centrifugation.
The mixture of tubules was suspended in 42% Pcrcoll made
isotonic with 10 x concentrated Krebs-Ringer buffer, and was
centrifuged (17,000 rpm; 30 mm; 4°C). The F4 layer, made of
proximal tubules, was suspended in HBS-Hepes, and was washed
and centrifuged (400 x g; 3 mm; 4°C). The final pellet was
suspended in culture medium with 1 % fetal bovine serum and
tubules were seeded in 6-well plastic trays or 10-cm culture dish.
Serum-free culture medium consisted in a 1:1 (vol/vol) mixture of
Ham's F-12 and Dulbecco's modified Eagle's medium containing
25 mlvi Hepes, 21.5 ms HCO1, 1 mivi Na pyruvate, 100 X
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Fig. 2. (A and B) Dose-dependent effect of HMG-CoA reductase inhibitors on DNA fragmentation. Subconfluent mouse proximal tubular (MPT) cells
were incubated with various concentrations of HMG-CoA reductase inhibitors for 24 hours. Symbols are: (0) lovastatin, (A) simvastatin; (0) compactin.
(Cand D) Time course of effect of lovastatin on DNA fragmentation. MPT cells were incubated with 25 JLM lovastatin for the time indicated. Percent
DNA fragmentation was calculated by the formula in the text. Values arc expressed as means SEM (N 4). Nucleic acid from each sample was
subjected to electrophoresis on a 1% agarose gel. P < 0.05, P < 0.01 versus cells without lovastatin. The experiment was repeated on three separate
occasions with similar results.
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Fig. 3. Effect of lovastatin on nucleus. MPT
cells were incubated in absence (A) or in
presence (B) of 25 gvt lovastatin for 24 hours.
The cells were stained with Hoechst 33258. Bar
represents tO jim. Arrowheads in b indicate
cleavage of nuclei.
non-essential amino acid mixture (final concentration IX), 4 mM
L-glutamine, 5t) U/mi penicillin, 50 mg/mI streptomycin, 100 nat
sodium selenite, 0.5 j.rg/ml insulin, 35 tg/ml transferrin, S n
tri-iodothyronine,l00 nat dexamethasonc, PGE1 25 ng/ml and
retinnic acid 0.5 tiM. Medium was changed after three days into
serum-free culture medium, and then on alternate days. Mono-
layers of proximal cells reached sub-confluence after four to five
days. The cells were incubated with agents for the indicated time
in fresh medium without hormones such as insulin, dexametha-
sone, tri-iodothyronine, retinoic acid and PGE1.
Electrophoretic analysis of DNA fragmentation
To assess DNA fragmentation, soluble (fragmented) DNA was
obtained basically as described [34] with some modifications.
Briefly, to prepare samples for gel electrophoresis, 1 X 1O cells
were lysed by incubation in 200 jd lysis buffer of 10 mat Tris-HC1,
pH 7.5, 10 mat EDTA, 0.5% Triton X-100 for 10 minutes at 4°C.
The lysates were centrifuged at 27,000 X g for 20 minutes and the
supernatant was incubated with 0.4 mg/mi RNase for one hour at
37°C and 0.4 mg/mi pruteinasc K for one hour at 37°C. The
fragmented DNA present in the supernatant was extracted and
precipitated in 50% isopropanol and 0.5 M NaCI. The samples
were resuspended in 20 d of 10 mat Tris-ItCI (pH 7.4) and 0.5 m
EDTA and separated by electrophoresis on a 1% agarose gel
containing ethidium bromide.
DNA fragmentation assay
DNA fragmentation was assessed by the method of Duke,
Chervenak and Cohen [351 with some modifications. Cells, la-
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Fig. 4. Effect of mevalonate metabolites on lovastatin-induced DNA fragmentation. (A) MPT cells were incubated with 25 /LM lovastatin in the presence
of increasing concentrations of mevalonate metaholites. Percent DNA fragmentation was determined by the method in the text. Values are expressed
as means SEM (N = 4). *P < 0.05, **P < 0.01 versus lovastatin-treated cells without mevalonate metabolites. (B) MPT cells were incubated with
lovastatin 25 jrM in the presence or the absence of mevalonate metabolites. Extracted DNA was analyzed by gelelectrophoresis: (lane 1)100 bp DNA
ladder, (lane 2) untreated cells, (lane 3) lovastatin 25 !LM alone, (lane 4) + mevalonate 500 sM, (lane 5) + GGPP 20 rM, (lane 6) + FPP 20 j.M.
Abbreviations are: GGPP, geranylgeranylpyrophosphate; FPP, farnesylpyrophosphate. The experiment was repeated on at least three separate
occasions with similar results.
fresh medium in the absence or the presence of the relevant
agents for the time indicated. At the end of the experiments, the
incubation medium was carefully withdrawn and saved. The cells
were lysed with the lysis buffer mentioned above and centrifuged
at 27,000 X g at 4°C for 20 minutes to separate intact chromatin
(pellet) from fragmented DNA (supernatant). The radioactivity
present in the incubation medium, in the supernatant and in the
pellet was counted by a liquid scintillation counter. Specific DNA
fragmentation was calculated by the formula: % specific DNA
fragments = 100 X cpmf.ags/cpmtotl; where cpmfUS,. = the cpm in
the incubation medium plus the cpm in the 27,000 g supernatant,
and the cpmtoti = cpmtag plus the cpm in the 27,000 g pellet.
Staining of nucleus and actin filaments
Cells harvested on coverslips were grown subconflucntly. Rho-
daminc phalloidin solution was prepared by dissolving I IU
rhodamine phalloidin in 200 d PBS per well. After washing cells
with PBS twice, the cells were fixed with 4% formaldehyde for 10
minutes. The cells were permeabilized by incubation with 0.1%
Triton X-100 for five minutes. After washing twice with PBS, the
cells were incubated with the rhodamine phalloidin solution for 30
minutes. After washing twice with PBS, cells were incubated with
2 .rg/ml Hoechst 33258 for five minutes. The solution was
aspirated and the cells were washed with PBS three times for the
examination under fluorescent microscope.
Statistics
The results were expressed as mean standard error (sEM) and
analyzed by using unpaired t-test. Each Figure is a representative
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Fig. 5. Effects of ts-hydroxyfarnesylphosphonic acid (HFPA) and perillic acid on MPT cells. MPT cells were incubated with various concentrations of
HFPA and perillic acid for 24 hours. (A) Percent DNA fragmentation was calculated by the formula in the text. Values are expressed as means SCM
(N = 4). *P < 0.05, < 0.01 versus control cells. (B) Nucleic acid from each sample was subjected to electrophoresis on a 1% agarose gel.
RESULTS
HMG-CoA inhibitors induce proximal tubule cells apoptosis
Cells were incubated with three different HRI for 24 hours.
Dose-response curves were established for each of these drugs
(Fig. 2A). DNA extracted from MPT cells were subjected to
agarose gel electrophorcsis. The DNA extracted from lovastatin-
treated cells was visualized as a series of bands corresponding to
integer multiples of 180 to 200 base pairs that is characteristic to
apoptosis (Fig. 2B). Similar bands werc visible in samples from
untreated cells, although the image was faint. As shown in Figure
2, C and D, more than 12 hours of incubation was needed to
induce DNA fragmentation. To further substantiate the morpho-
logical changes, we stained nuclei with a dye, Hoechst 33258,
which specifically binds to chromatin. Lovastatin-treated cells
showed fragmented nuclei (Fig. 3). A number of apoptotie bodies,
which are small membrane-bound bodies containing fragments of
highly condensed DNA, appeared after 24 hours of incubation
with lovastatin.
Involvement of isoprenylation in HRI-induced apoptosis
To spcci1 the factors which are responsible for the HRI-induecd
apoptosis, mevalonate metabolites were added in medium and
incubated for 24 hours in the presence of lovastatin. Mevalonate (500
JIM) and GGPP (20 JIM) completely reversed the lovastatin effect,
while FPP (20 JIM) partially suppressed it (Fig. 4). Other HMG-CoA
metabolites such as ubiquinone (10 tg/ml), dolichol (5 JIg/mI),
isopentenyladenine (10 JIg/mi) and cholesterol (100 JIg/mI) had no
effect on DNA fragmentation (data not shown). To substantiate the
involvement of isoprenylation in HRI-induced apoptosis, HFPA and
perillic acid, isoprenylation inhibitors, were added in medium and
incubated for 24 hours in the presence of lovastatin. HFPA is an
inhibitor relatively specific to farnesylpyrophosphatase (FPTase); the
reported 1C50 values for FPTase and geranylgeranylpyrophos-
phalase-I (GGPTase-I) are 30 nM and 35,800 nM, respectively [36,
3I Perillic acid is a nonspecific inhibilor of isoprenylation (38].
There was no significant increase in DNA fragmentation of the cells
treated with up to 51)0 nM I-{FPA, while HFPA of concentrations
equal to or higher than 10 JIM and 5 mrvi perillic acid increased DNA
fragmentation. DNA ladder pattern on gel clectrophoresis was also
observed under the same conditions (Fig. 5). HFPA at high concen-
trations and 5 mM perillic acid are thought to inhibit not only FPTase
but also GGPTase. This result, together with that of GGPP supple-
mentation, indicates a critical role of geranylgeranylation in HRI-
induced apoptosis.
A
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Fig. 6. Effects of lovastatin on actin filaments and cell nucleus. MPT cells were incubated in the absence (a and e), and in the presence of 25 /.LM
lovastatin for six hours (b andD, for 24 hours (c andg), and 25 ,LLM lovastatin plus GGPP 20 M for 24 hours (d and h). Actin filaments and nuclei were
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Hill disrupt actin filaments
MPT cells grown on coverslips were incubated in the presence
or the absence of lovastatin. To examine the changes of actin
filaments and nucleus simultaneously in the same cells, MPT cells
were stained with rhodamine phalloidin and Hoechst 33258.
Rhodamine phalloidin is known to specifically bind to filamentous
actin (F-actin), but not to actin monomer [39]. MPT cells, under
normal conditions, contained actin filaments which transverse the
cells and end to plasma membrane (Fig. 6). In contrast, a six hour
incubation with 25 LM lovastatin induced a variation between cells
as regards actin filaments content. The cells were weakly stained
with the dye compared with normal control cells, indicating a
decrease in actin filaments. Remaining actin filaments spanning
cytoplasm were found to be detached from the cell-cell junction at
plasma membrane, which is producing a linear dark area between
the plasma membrane and the cytoplasmic actin filaments. There
was no cleaved nucleus even in the cells with the actin filaments
disrupted by the six hour incubation with lovastatin. On the other
hand, 24 hours of incubation with lovastatin induced nucleus
cleavage in the cells; those cells completely lost actin filaments.
Some cells showed diffuse and punctatc staining by rhodamine
phalloidin. To examine the effect of geranylgeranylation on the
actin filament disruption, cells were incubated with lovastatin in
the presence of GGPP, GGPP (20 /LM) inhibited the actin
filament disruption.
To determine whether actin disruption itself induces apoptosis,
MPT cells were incubated with cytochalasin D. ytochalasin D is
about 10 times more effective than cytochalasin B in binding actin,
and does not bind to the glucose transporter, as do some
cytochalasins, including cytochalasin B [40]. ytocha1asin D
caused DNA fragmentation in a dose dependent manner. As
shown in Figure 7, 1 M cytochalasin D, which completely
disrupted actin filaments, induced apoptosis as assessed both
morphologically by staining with Hoechst dye and biochemically
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Fig. 7. Effect of cytochalasin D on MPT cells. MPT cells were incubated
with cytochalasin D for 24 hours. (A) Percent DNA fragmentation was
calculated by the formula in the text. Values are expressed as means
SEM (N = 4). **P < 0.01 versus untreated cells. (B) Nucleic acid from each
sample was subjected to electrophoresis on a 1% agarose gel. (Lane 1)100
kb DNA ladder marker, (lane 2) untreated cells, (lane 3) 1 jzu Cytocha-
lasin D. (C) Actin filaments were visualized with rhodamine phalloidin (a)
and nuclei with Hoechst 33258 (b) in the same cells. Bar represents 10 rm.
Arrowheads in b indicate cleavage of nuclei. The experiment was repeated
on three separate occasions with similar results.
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Table 1. ICE inhibitor and apoptosis
Fragmented-DNA %
ICE inhibitor II p.M
0 50
Control 7.1 0.22 7.6 0.16
Lovastatin 25 pii 15.9 0.75 16.8 0.44
Cytochalasin D I p.M 18.4 1.03 17.3 0.78
Cisplatin 20 p.gIml 16.1 0.45 12.0 0.72a
MPT cells were incubated for 24 hours in the absence or in the presence
of ICE inhibitor II, with the agents.
Results are mean SEM (N = 6).
ap <0.01
Involvement of protease in HRI-induced apoptosis
Interleukin-l/3 converting enzyme (ICE), a pro-apoptotic pro-
tease, was found to cleave actin and induce inactivation of the
actin [41]. To investigate whether ICE is involved in HRI-induced
apoptosis, cells were incubated with ICE inhibitor II, a cell
permeable inhibitor of ICE [421, in the presence of several
apoptosis-inducing agents such as lovastatin, cisplatin and cy-
tochalasin D. While ICE inhibitor II partially inhibited cisplatin-
induced DNA fragmentation, which is in agreement with the
previous study by Takeda, Kobayashi and Endou [43], the inhib-
itor had no effect on either lovastatin- or cytochalasin D-induced
DNA fragmentation (Table 1).
DISCUSSION
In this study, we investigated the effects of HMG-CoA reduc-
tase inhibitors (HRI) on mouse proximal tubule (MPT) cells in
primary culture, and found that lovastatin and two other HRI
induce apoptosis.
HRI are used clinically for the treatment of patients with
hypercholesterolemia. However, these drugs have been reported
to have an antiproliferative and/or apoptosis-inducing effect in
several cell types. As shown in Figure 1, HRI suppress the
production of HMG-CoA metabolites such as ubiquinone, doli-
chol, cholesterol, isopentenyladenine and isoprenoids.
Our results suggest the involvement of isoprenoids such as
farnesylpyrophosphate (FPP) and geranylgeranylpyrophosphate
(GGPP) in HRI-induced apoptosis. GGPP completely reversed
the lovastatin effect in the absence of upstream intermediates in
the HMG-CoA pathway. Furthermore, farnesylation inhibitors
did not induce apoptosis at concentrations of 1C50 for FPTase,
but they induced apoptosis at higher concentrations. These high
concentrations were supposed to inhibit not only farnesylpyro-
phosphatase (FPTase), but also geranylgeranylpyrophosphatase
(GGPTase). These results suggest that geranylgeranylation is a
critical process in HRI-induced apoptosis.
Prenylated proteins are divided into three different classes
based on their C-terminal sequences and protein transferase
dependency [21]. The first group proteins including Ras proteins
and nuclear lamins are prenylated by FPTase. FPP is used as the
modifying moiety. The second group proteins are prenylated by
GGPTase I. This group includes most of the members of the Rho
proteins such as rho, rae, rat and G25K. The third group proteins
are prenylated by GGPTase II using GGPP as the moiety. Rab
proteins are known to be included in the third group. The role of
Rho sub-family proteins in cell function is less well understood
than that of Ras sub-family proteins. However, it has been
recently brought to light by the studies over the last few years that
the Rho sub-family members are playing a key role in actin
cytoskeleton organization. Micro-injection of activated Rho pro-
tein into Swiss 3T3 cells stimulated actin stress fiber and focal
adhesion formation [22]. Rac and CDC42, members of the Rho
sub-family, were found to be involved in actin-based structure,
lamellipodia and filopodia, respectively [23]. Micro-injection of
rhoGDP dissociation inhibitor, an inhibitor of rho protein, in-
duced disappearance of actin stress fibers [24]. In the present
study, GGPP supplementation suppressed not only lovastatin-
induced apoptosis, but also the actin filament disruption by
lovastatin. From these data and the results previously reported,
we speculate that actin filament disorganization in HRI-treated
cells may result from inhibition of geranylgeranylation of proteins
belonging to the Rho sub-family.
Recently, interleukin-1B (ICE), a member of ICE-like pro-
teases, was found to cleave actin protein followed by DNA
fragmentation [41]. This report led us to suspect that the actin
filament disruption by lovastatin may be caused by the activation
of ICE. In our hands, however, ICE inhibitor II, which is known
to inhibit ICE (Ki = 0.76 nM) and CPP32/Apopain (Ki = 12 p.M)
[42, 44], had no effect on HRI-induced DNA fragmentation.
Although this does not rule out the possibility that other members
of ICE-like proteases such as Nedd-2, Mch2, ICEreill and
ICErellil are involved in apoptosis, it seems to be unlikely that
either ICE or CPP32 play some role in HRI-induced apoptosis.
Moreover, the efficiency of the ICE inhibitor was confirmed by the
partial reversion of cisplatin-induced apoptosis.
While six hours of treatment with lovastatin induced actin
filament disruption, we could not evidence a cleaved nucleus in
the same cell at that time. As shown by the DNA fragmentation
assay, more than 12 hours of treatment with lovastatin was needed
for DNA fragmentation. Taken together, the actin filament
disruption, preceding DNA fragmentation, appeared to occur in
the early phase of this HRI-induced apoptosis. Although it does
not necessarily indicate that actin filament disruption is the only
early event in HRI-induced apoptosis, this temporal dissociation
between actin disruption and DNA fragmentation suggests the
possibility that actin filament disruption is instrumental in DNA
fragmentation via an unknown mechanism.
Involvement of actin organization in apoptosis has been re-
ported in several cell types. In human endothelial cells, disorga-
nization of actin filaments was observed in apoptotic cells [27].
This apoptosis was prevented by coating culture dishes with
fibronectin and vitronectin which are both known to have a close
connection with actin cytoskeleton via integrin. More directly,
cytochalasins were demonstrated to induce DNA fragmentation
in rat proximal tubular cells [29] and in other cell types [45]. In the
present study, we recognized that cytochalasin D induced DNA
fragmentation of MPT cells. The morphological changes showed
the features characteristic to apoptosis.
One possible explanation of the relationship between alteration
of actin filament integrity and apoptosis is that the actin disrup-
tion may activate DNases which are known to be responsible for
internucleosomal DNA fragmentation in apoptosis of some cell
types [46]. Actin makes a complex with DNase in a nucleus, which
prevents the activation of the DNase [46, 47]. Thus, it is conceiv-
able that actin disorganization activates DNase by liberating the
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enzyme from the complex. Actually, the actin cleaved by ICE was
found to be unable to inhibit DNase 1 [41].
In conclusion, the present study showed the potential of
HMG-CoA reductase inhibitors (HRI) as an apoptosis-inducing
agent in proximal tubular cells, and proposed the involvement of
isoprenylation, in particular the role of geranylgeranylation in the
apoptosis induction. Actin filament disorganization may play
some role in the apoptosis, although a more detailed knowledge
of changes in actin filaments in connection with both HRI action
and apoptosis is needed in order to determine the involvement of
actin cytoskeleton in HRI-induced apoptosis. Biological signifi-
cance of this apoptosis would be evaluated by in vivo experiments.
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APPENDIX
Abbreviations used in this paper are: HMG-CoA, hydroxy-3-methylglu-
taryl coenzyme A; HRI, HMG-CoA reductase inhibitors; FPP, farnesylpy-
rophosphate; GGPP, geranylgeranylpyrophosphate; MPT, mouse proximal
tubular cells; HFPA, cs-hydroxyfarnesylphosphonic acid; ICE, interleukin-1B-
converting enzyme; FFTase, farnesylpyrophosphatase; GGPTase-I, gera-
nylgeranylpyrophosphatase-1.
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